Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Talks SJ, Gupta R, Browning A . Alternative diagnosis for cases presented as vPED treated with high-dose ranibizumab. Eye 2012; 26 (12): 1599–1600.
Chan CK, Abraham P, Sarraf D . High-dose ranibizumab therapy for vascularized pigment epithelial detachment. Eye 2012; 26 (6): 882–885.
Gass JD, Norton EW, Justice J . Serous detachment of the retinal pigment epithelium. Trans Am Acad Ophthalmol Otolaryngol 1966; 70: 990–1015.
Gass JD . Serous retinal pigment epithelial detachment with a notch. A sign of occult choroidal neovascularization. Retina 1984; 4: 205–220.
Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular, degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991; 109: 1242–1257.
Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No 2. Arch Ophthalmol 2003; 121: 1253–1268.
Acknowledgements
This study was supported by Genentech Inc. (CKC, PA, DS), Owen Locke Foundation (CKC), and Karl Kirchgessner Foundation (DS). This report constitutes the clinical application of a non-FDA approved dosage of an FDA approved medication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Chan, C., Abraham, P. & Sarraf, D. Response to Talks et al. Eye 26, 1600–1601 (2012). https://doi.org/10.1038/eye.2012.209
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2012.209
